LEAH HERMANSON: Open Payments
NPI 1063959518 · SEDALIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,403 in 67 payments from 15 companies in 2025. Trend: 2023 $171 · 2024 $624 · 2025 $1,403
Food & beverage: $1,403
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $409 |
| GENZYME CORPORATION | 12 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $136 |
| Grifols USA, LLC | 5 | $109 |
| GlaxoSmithKline, LLC. | 6 | $104 |
| Dexcom, Inc. | 3 | $77 |
| Verona Pharma, Inc. | 4 | $75 |
| Viatris Specialty LLC | 3 | $74 |
| JAZZ PHARMACEUTICALS INC. | 2 | $47 |
| Insmed, Inc. | 2 | $45 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, Prolastin-C Liquid, NUCALA, TEZSPIRE, OFEV, Dexcom G6 Transmitter.
Industry payments across MO — which companies pay providers there.
